As cell and gene therapies continue to make headlines as a key opportunity for growth, success in this field will require both innovative tech as well as strategic foresight.

Project Farma has led more than a dozen manufacturing facility builds with capital investments greater than $1 billion (including some of the leading FDA-approved cell and gene therapy medicines).

Project Farma provides Precision a market-leading expertise in the manufacturing of life-changing medicines, with a unique focus in the rapidly growing area of cell and gene therapy.

As cell and gene therapy grows rapidly, life sciences manufacturers will soon encounter new challenges, including a fundamental shift from ‘made-to-stock’ to ‘made-to-order', says Bryan ...

Where some gene therapy players might “go big” and put down brick and mortar facilities, Avrobio went the opposite direction. | Cell and gene therapies are already revolutionizing treatment ...

Bharat Biotech is pumping $75 million into a new cell and therapy manufacturing facility at the Indian drugmaker’s facility located in what is known as Genome Vally in Hyderabad.

Recommendations The development of cell and gene therapies calls for a standard application of risk management principles in line with the current guidelines for product development.

Students learn how to manage everything from pre-clinical IND-enabling studies to product licensure, and into post-approval life cycle management, post-approval change reporting categories, ...

Standardization in the cell and gene therapy industry is not easy. Stakeholders from across the industry must come together to develop, agree on, and adopt a standard because standards must ...

Cell and gene therapy research has been hot the past few years but the overall market has cooled down in recent months. During the World Medical Innovation Forum in Boston, a panel of venture ...